✓ No loaded language, vague sourcing, or framing detected.
Flow Neuroscience has launched a wearable device for depression treatment in the US, approved by the FDA in December 2022. The device, which provides low-intensity electrical stimulation to the brain, has shown promising results in clinical trials, with 45% of participants experiencing symptom remission. However, it comes with a high price tag, requiring patients to pay out of pocket for its use.
Our neutral summary
Flow Neuroscience has launched a wearable device for depression treatment in the US, approved by the FDA in December 2022. The device, which provides low-intensity electrical stimulation to the brain, has shown promising results in clinical trials, with 45% of participants experiencing symptom remission. However, it comes with a high price tag, requiring patients to pay out of pocket for its use.
The reporting belongs to Wired; we don't reproduce it.
No note attached
on this article.
A New Headset to Help With Depression Is Now Available in the US
New Wearable Device for Depression Treatment Available in the US